Translational Research Institute Australia ads

TRI is pleased to have welcomed Dr Steve Burnell and Dr Mike Lamprecht from Tenmile, offering CEO Professor Maher Gandhi the opportunity to showcase our cGMP manufacturing facility ENTRI and TRI's industry incubator space. ENTRI is due for completion in 2026. The facility will transform Australia’s cGMP manufacturing options and position the nation as a global biomedical innovation hub. ENTRI is proudly funded by the Queensland Government and TRI. Thank you, Sue Coke and Sarah Roberts from the Department of State Development, Infrastructure and Planning; and TRI Head of Commercial Operations Dr Ryan Parlett. Read more about ENTRI or lodge an Expressions of Interest: https://lnkd.in/gdERiN6M

TRI-based Professor Katharina Ronacher from Mater Research has led the first study in the world to examine lung immune cells from people with diabetes who have been exposed to TB. The study has found type 2 diabetes disrupts the lung’s frontline immune cells, creating an environment where TB bacteria thrive. People with diabetes are three times more likely to develop TB, study first author Dr Léanie Kleynhans has found. TB is the leading cause of death from a single infectious pathogen, claiming 1.25 million lives annually. Popular holiday destination Bali is among the world's TB hotspots. Read more: https://lnkd.in/g7WUUaXb Stellenbosch University The Lancet Group

Researchers at TRI have used the latest microchipping technology to confirm what office workers have long suspected – that teaspoons disappear from workplace tearooms at a consistent rate. TRI CEO Professor Maher Gandhi has led the research, finding teaspoons are lost at a rate of exactly 2.58 teaspoons per person per 100 teaspoon years in communal tearooms. No teaspoon companies were involved in the funding of the study. TRI researchers not only save lives but also have a sense of humour! Happy holidays from TRI. Read more: https://lnkd.in/ggGFJxH3 Pictured: TRI Director of Corporate Affairs and Marketing Shari Armistead GAICD FIML, Professor Gandhi and Director of Service Delivery and Quality Emily Duggan.

Work with us! TRI is looking for a Manager, Industry and Commercial Operations. The position will support TRI's growth by driving industry engagement, business development and sales, and tenancy management across TRI and our cGMP manufacturing facility ENTRI. Applications close 5pm on Monday 15 December. Read more: https://lnkd.in/d9rMEy3e

TRI-based Dr Abbas Shafiee from The University of Queensland UQ Frazer Institute has been awarded a prestigious LEO Foundation // LEO Fondet research grant. The competitive grant supports the best dermatology research projects worldwide. Dr Shafiee’s project aims to create the first human skin organoid model that faithfully mimics real skin — a breakthrough that could enable testing of personalised, targeted therapies and open new pathways for regenerative skin research. The research team includes UQ Professor Kiarash Khosrotehrani and Professor Neil Rajan from Newcastle University. Jane Sun Imaan Ahmed Mitchell Mostina Seen Ling Sim Metro North Health

Thank you, 612 Australian Broadcasting Corporation (ABC) Breakfast Show co-hosts Loretta Ryan and Craig Zonca for sharing our CEO's quirky sense of humour. TRI CEO Professor Maher Gandhi appeared on the radio show today, with a tongue-in-cheek chat about disappearing teaspoons, as well as the serious side of medical research undertaken at TRI.